This statement is made pursuant to Section 54 of the Modern Slavery Act 2015 and California Transparency in Supply Chains Act of 2010 (SB 657) and sets out the steps Bausch + Lomb UK Ltd has taken to ensure that slavery and human trafficking is not taking place in our supply chains or in any part of our business. It constitutes our slavery and human trafficking statement for the financial year 2018/19.
Bausch + Lomb established in 1853 in Rochester, New York, as a small optical shop which grew to become a large healthcare company with over 10,000 employees in 100 plus countries around the world. Since our establishment, Bausch + Lomb has been at the forefront of visionary innovations in eye care, dedicated to perfecting vision and enhancing life. We have over 150 years of experience in delivering ophthalmic products and services globally and our history of innovation continues today as we invent new materials, engineer new technologies, and create pioneering ways to help people see better.
Bausch + Lomb is a diverse multinational healthcare company. As a company of Bausch Health Companies Inc., Bausch + Lomb is even better positioned to enrich its portfolio in the eye care market sector, whilst bringing its wealth of experience into new areas and diversifying into wider therapeutic areas in healthcare.
Our products and services include:
Bausch + Lomb currently delivers products and services to approximately 3,500 customers in the United Kingdom. Our customer base has been essential in enabling Bausch + Lomb to pioneer new technology in this arena and continuously improve our systems in the last ten years. The UK subsidiary comprises of 3 product and service lines:
The UK organisation currently employs around 150 staff, fostering a ‘small company’ mind-set with the comfort of a large financial backer from the wider group. We take pride in a team that is wholly dedicated to working in strong collaboration with each other and sharing knowledge and skills readily in order to further the unified company success.
Bausch + Lomb, is a leading global eye health organization that is solely focused on protecting, enhancing and restoring people’s eyesight. Our core businesses include ophthalmic pharmaceuticals, contact lenses and lens care products, as well as ophthalmic surgical devices and instruments. We globally develop, manufacture and market one of the most comprehensive product portfolios in our industry, which is available in more than 100 countries.
Our Amsterdam Logistics Centre is based at Schiphol-Rijk. From this site our products in all categories are stored, picked, packed and shipped to customers in over 100 countries worldwide. Our logistics centre is the largest distribution centre for Bausch + Lomb employing 200 people handling 30,000 order lines a day.
Bausch Health Companies Inc. ensures the compliance of environmental health, safety and sustainability principles by being practical, non-burdensome, collaborative and proactive. Our environmental health, safety and sustainability principles are included in our operating plans, have the ability to influence and motivate across regions and to motivate local leadership in our decentralized organization model.
These principles are designed to support the achievement of our business objectives and meet the needs of patients, customers, consumers, regulators and stakeholders today whilst protecting and sustaining the community, environment and natural resources so they are available for future generations.
Beginning in 2015, we raised our sustainability efforts to Board Director level by establishing an Environmental, Health, Safety and Sustainability Subcommittee. During the period 2015-2017, the company implemented a number of initiatives:
Today, Bausch + Lomb continues its sustainability journey and its work to implement economically sound processes that minimize negative environmental impacts, whilst conserving energy and natural resource via initiatives such as CO₂ reduction being introduced as a criteria in tenders and business reviews with carriers, a ‘make to order’ project to reduce carton waste, lease car policy changes based on CO₂ emissions and reducing night KWh usage.
Trust, mutual respect and ethical behaviour are essential to Bausch + Lomb relationships with our eye care professional partners, our customers, our employees and our investors. In these relationships, we must conduct our business with the highest ethical standards — always ensuring that our behaviours are consistent with both the letter and the spirit of Company policies, laws and regulations — and with the exercise of good business judgment.
Through the Bausch + Lomb Code of Business Conduct and Ethics, we publicly commit every employee to uphold the highest standards of business conduct and ethics — complying with laws, avoiding conflicts of interest, beating the competition ethically, meeting our business goals the right way, treating our diverse employees fairly and with respect and maintaining a safe and healthy work environment for all employees. For more than 150 years, our company has enhanced the lives of millions of people around the world. We are committed to continuing this great tradition by living up to the standards we have set for ourselves in our code and exhibiting an uncompromising commitment to integrity by everyone, every day, everywhere. More information on our Code of Business Conduct and Ethics can be found at https://bausch.co.uk/our-company.
Details of our Labour Standards Policy can be found at https://bausch.co.uk/our-company.
Developed by NHS Supply Chain, in conjunction with the Department of Health and industry bodies, LSAS provides an extra level of corporate, social and ethical governance with regards labour standards, marking a major but progressive change in its procurement methodology. In July 2017, the Surgical division of Bausch + Lomb achieved Level 2 of this standard. We will continue to work towards maintaining this accreditation with yearly audits and will aim to demonstrate additional improvements and enhancements to our processes.
Bausch + Lomb continues to work towards maintaining our Level 2 accreditation of LSAS, which includes ongoing training and awareness for our employees. It is our belief that the process and KPI’s that form part of Level 2 achievement will enhance our visibility and ability to identify modern slavery risks.
Approved by the UK Leadership Team and signed on its behalf by:
Mr Duncan Dow
General Manager, UK&I
Select an Age Group